Join to View Full Profile
1959 Ne Pacific StSeattle, WA 98195
Phone+1 206-667-5249
Are you Dr. Riddell?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Stanley Riddell, MD is an oncologist in Seattle, Washington. He is currently licensed to practice medicine in Washington. He is a Professor at University of Washington School of Medicine.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1985 - 1989
University of ManitobaClass of 1979
Certifications & Licensure
WA State Medical License 1986 - 2026
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsPhase I Study of ROR1-Specific CAR-T Cells in Advanced Hematopoietic and Epithelial Malignancies.Carla A Jaeger-Ruckstuhl, Jennifer M Specht, Jenna M Voutsinas, Hugh R MacMillan, Qian Vicky Wu
Clinical Cancer Research. 2025-02-03 - Phase I study of CD19 CAR T-cell therapy harboring a fully human scFv in CAR-naïve adult B-ALL patients.Jordan Gauthier, Emily C Liang, Jennifer J Huang, Erik Lesley Kimble, Alexandre V Hirayama
Blood Advances. 2025-01-16 - 1 citationsSingle-cell analysis of the multiple myeloma microenvironment after γ-secretase inhibition and CAR T-cell therapy.David G Coffey, Pinar Ataca Atilla, Erden Atilla, Ola Landgren, Andrew J Cowan
Blood. 2025-01-09
Press Mentions
Tip Sheet: Celebrate Holidays Safely, COVID-19 Vaccines, Challenges in HIV Vaccine Trials — and New Insights on EvolutionDecember 2nd, 2020- The Latest on Health Technology and Cancer TreatmentsAugust 20th, 2020
- Cancer Tor the Biography of Josef Issels Md Who Brought Hope to the World with His RevolutioJune 28th, 2020
- Join now to see all
Grant Support
- Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung CancerFRED HUTCHINSON CANCER CENTER2022–2027
- Novel synthetic receptors with improved antigen specificity and specificity for cancer therapyFRED HUTCHINSON CANCER CENTER2005–2026
- Novel synthetic receptors with improved antigen specificity and specificity for cancer therapyFRED HUTCHINSON CANCER CENTER2005–2026
